Furthermore, these changes of phenotypes induced by SphK1 blockage could be reversed by exogenous S1P addition (Figure 3D-3F), which suggested that SphK1 blockage attenuated the angiogenic potential of ovarian cancer cells partly through inhibition of S1P. The gene discussed is MBTPS1; the disease is ovarian cancer.